Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026

yf_tkr_WAT · 2026-10-23 · Bullish AI sentiment

$LH $WAT

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Waters Corporation (NYSE: WAT), a global life sciences and diagnostics leader, today announced a partnership to expand access to the FDA-approved BD Onclarity HPV Assay through Labcorp's nationwide laboratory network beginning in late 2026.

Sector coverage: Healthcare · Diagnostics & Research

Read the original at yf_tkr_WAT ↗

Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.